Recently, COL6A1 has been recognized as important for tumor growth and metastasis, and it has been reported to be expressed in a variety of cancers including cervical squamous cell carcinoma and pancreatic carcinoma [23, 24]. Here, COL6A1 is linked to exocrine pancreatic carcinoma.